Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 7.94
+0.08 (1.02%)
Feb 27, 2026, 3:00 PM CST
Chemclin Diagnostics Revenue
Chemclin Diagnostics had revenue of 96.21M CNY in the quarter ending September 30, 2025, a decrease of -18.61%. This brings the company's revenue in the last twelve months to 353.32M, down -20.40% year-over-year. In the year 2024, Chemclin Diagnostics had annual revenue of 436.29M, down -2.03%.
Revenue (ttm)
353.32M
Revenue Growth
-20.40%
P/S Ratio
8.87
Revenue / Employee
561.72K
Employees
606
Market Cap
3.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 436.29M | -9.05M | -2.03% |
| Dec 31, 2023 | 445.34M | -19.93M | -4.28% |
| Dec 31, 2022 | 465.27M | -5.50M | -1.17% |
| Dec 31, 2021 | 470.77M | 52.57M | 12.57% |
| Dec 31, 2020 | 418.20M | -36.47M | -8.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.47B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |
| Berry Genomics Co.,Ltd | 941.16M |
| SMO ClinPlus CO.,LTD. | 819.09M |